Disposition of ultrasound sensitive polymeric drug carrier in a rat hepatocellular carcinoma model.
Disposition of ultrasound sensitive polymeric drug carrier in a rat hepatocellular carcinoma model.
复制标题
DOI:
10.1016/j.acra.2011.06.013
复制
发表时间:
2011-11
影响因子:
4.8
通讯作者:
Wheatley, Margaret A.
中科院分区:
文献类型:
--
作者:
Cochran, Michael C.;Eisenbrey, John R.;Soulen, Michael C.;Schultz, Susan M.;Ouma, Richard O.;White, Sarah B.;Furth, Emma E.;Wheatley, Margaret A.
A doxorubicin-loaded microbubble has been developed that can be destroyed with focused ultrasound resulting in fragments, or “nanoshards” capable of escaping through the leaky tumor vasculature, promoting accumulation within the interstitium. This study utilizes a rat liver cancer model to examine the biodistribution and tumoral delivery of this microbubble platform compared with de novo drug-loaded polymer nanoparticles and free doxorubicin. Microbubbles (1.8µm) and 217nm nanoparticles were prepared containing 14-C labeled doxorubicin. Microbubbles, nanoparticles, a combination of the two, or free doxorubicin were administered intravenously in rats bearing hepatomas, concomitant with tumor insonation. Doxorubicin levels in plasma, organs and tumors were quantified after 4hours, 7 and 14days. Tumors were measured upon sacrifice and evaluated with autoradiography and histology. Animals treated with microbubbles had significantly lower plasma doxorubicin concentrations (0.466±0.068%/ml) compared with free doxorubicin (3.033±0.612%/ml, p=0.0019). Drug levels in the myocardium were significantly lower in animals treated with microbubbles compared to free doxorubicin (0.168%/g tissue vs. 0.320%/g, p=0.0088). Tumors treated with microbubbles showed significantly higher drug levels than tumors treated with free doxorubicin (2.491±0.501 %/g vs. 0.373±0.087 %/g, p=0.0472). These tumors showed significantly less growth than tumors treated with free doxorubicin (p=0.0390). Doxorubicin loaded microbubbles triggered with ultrasound provided enhanced, sustained drug delivery to tumors, reduced plasma and myocardium doxorubicin levels and arresting tumor growth. The results offer superior treatment than injection of de novo synthesized nanoparticles.
登录
查看更多内容
影响因子:
10.8
作者:
Kooiman, Klazina;Bohmer, Marcel R.;van Wamel, Annemieke
通讯作者:
van Wamel, Annemieke
影响因子:
37.8
作者:
Price, RJ;Skyba, DM;Skalak, TC
通讯作者:
Skalak, TC
影响因子:
10.8
作者:
Maeda, H;Wu, J;Hori, K
通讯作者:
Hori, K
DOI:
10.1007/s00259-010-1449-6
发表时间:
2010-08-01
影响因子:
9.1
作者:
Eisenbrey, J. R.;Forsberg, F.
通讯作者:
Forsberg, F.
影响因子:
10.8
作者:
Eisenbrey, J. R.;Burstein, O. Mualem;Kambhampati, R.;Forsberg, F.;Liu, J. -B.;Wheatley, M. A.
通讯作者:
Wheatley, M. A.